{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:16:15Z","timestamp":1788628575450,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020052","name":"National Centre for Cell Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science &amp; Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152727","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:12:30Z","timestamp":1759248750000},"page":"152727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeting IL-6\/STAT3 signaling to mitigate sarcopenia: Insights from immuno-metabolic crosstalk in NSCLC"],"prefix":"10.1016","volume":"786","author":[{"given":"Gautam","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5481-8321","authenticated-orcid":false,"given":"Shweta","family":"Khandibharad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-8819","authenticated-orcid":false,"given":"Shailza","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152727_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbrc.2025.152727_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.152727_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3389\/fonc.2020.00593","article-title":"Differentiating peripherally-located small cell lung cancer from non-small cell lung cancer using a CT radiomic approach","volume":"10","author":"Chen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11071982","article-title":"Small cell lung carcinoma: current diagnosis, biomarkers, and treatment options with future perspectives","volume":"11","author":"Krpina","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2025.152727_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152727_bib6","first-page":"288","article-title":"Non-small cell lung cancer: current treatment and future advances, transl","volume":"5","author":"Zappa","year":"2016","journal-title":"Lung Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152727_bib7","first-page":"1411","article-title":"Clinicopathologic features of advanced squamous NSCLC","volume":"11","author":"Socinski","year":"2016","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer."},{"key":"10.1016\/j.bbrc.2025.152727_bib8","first-page":"189","article-title":"Lung cancer: biology and treatment options","volume":"1856","author":"Lemjabbar-Alaoui","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2025.152727_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5306\/wjco.v8.i1.1","article-title":"Therapeutic management options for stage III non-small cell lung cancer","volume":"8","author":"Yoon","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16122205","article-title":"Promising combinatorial therapeutic strategies against non-small cell lung cancer","volume":"16","author":"Kaur","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2025.152727_bib11","first-page":"1267","article-title":"Immune checkpoint inhibitors in EGFR-mutated NSCLC: dusk or dawn?","volume":"16","author":"Qiao","year":"2021","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer."},{"key":"10.1016\/j.bbrc.2025.152727_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.drudis.2017.05.011","article-title":"Advances in antibody-drug conjugates: a new era of targeted cancer therapy","volume":"22","author":"Sau","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrc.2025.152727_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216894","article-title":"Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies","volume":"591","author":"El-Tanani","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.152727_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2025.152727_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152727_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fonc.2020.01290","article-title":"Mechanisms of cancer resistance to immunotherapy","volume":"10","author":"Bai","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13046-025-03302-0","article-title":"Tumor secretome shapes the immune landscape during cancer progression","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152727_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5563746","article-title":"Role of cytokines and chemokines in NSCLC immune navigation and proliferation","volume":"2021","author":"Ramachandran","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2025.152727_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.152727_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.152727_bib21","first-page":"684","article-title":"Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer","volume":"4","author":"Zhang","year":"2021","journal-title":"Cancer Drug Resist. (Alhambra, Calif.)"},{"key":"10.1016\/j.bbrc.2025.152727_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117590","article-title":"Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: implications for cancer therapy","volume":"180","author":"Qi","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152727_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2013.08.004","article-title":"Interleukin-6: an angiogenic target in solid tumours","volume":"89","author":"Middleton","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2025.152727_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40001-017-0266-9","article-title":"A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-\u03b1","volume":"22","author":"Bian","year":"2017","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrc.2025.152727_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fphys.2019.00500","article-title":"The JAK\/STAT pathway in skeletal muscle pathophysiology","volume":"10","author":"Moresi","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrc.2025.152727_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jcsm.12867","article-title":"Sepsis induces interleukin 6, gp130\/JAK2\/STAT3, and muscle wasting","volume":"13","author":"Zanders","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle."},{"key":"10.1016\/j.bbrc.2025.152727_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib28","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.1074\/jbc.M115.641514","article-title":"Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia","volume":"290","author":"Silva","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.152727_bib29","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2025.152727_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib31","first-page":"75","article-title":"Review of tocilizumab in the treatment of rheumatoid arthritis","volume":"2","author":"Okuda","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.bbrc.2025.152727_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac003","article-title":"Resistance exercise as a treatment for sarcopenia: prescription and delivery","volume":"51","author":"Hurst","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.bbrc.2025.152727_bib33","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2010.06.019","article-title":"SnapShot: key numbers in biology","volume":"141","author":"Moran","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.152727_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13670","article-title":"Succinate regulates exercise-induced muscle remodelling by boosting satellite cell differentiation through succinate receptor 1","volume":"16","author":"Shi","year":"2025","journal-title":"J. Cachexia. Sarcopenia Muscle."},{"key":"10.1016\/j.bbrc.2025.152727_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188837","article-title":"Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer","volume":"1878","author":"He","year":"2023","journal-title":"Biochim. Biophys. Acta. Rev. Cancer."},{"key":"10.1016\/j.bbrc.2025.152727_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10040572","article-title":"Acetyl-CoA metabolism and histone acetylation in the regulation of aging and lifespan","volume":"10","author":"Bradshaw","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.152727_bib37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cmet.2019.08.014","article-title":"Nuclear glycogenolysis modulates histone acetylation in human non-small cell lung cancers","volume":"30","author":"Sun","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrc.2025.152727_bib38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1172\/JCI90277","article-title":"DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade","volume":"128","author":"Touat","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.152727_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1464815","article-title":"Mechanisms of the NAD(+) salvage pathway in enhancing skeletal muscle function","volume":"12","author":"Su","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152727_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-0805-9_11","article-title":"Modeling and simulation using CellDesigner","volume":"1164","author":"Matsuoka","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2025.152727_bib41","article-title":"Epigenetic alterations and inflammation as emerging use for the advancement of treatment in non-small cell lung cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152727_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells12060905","article-title":"A systematic review of progress toward unlocking the power of epigenetics in NSCLC: latest updates and perspectives","volume":"12","author":"Sulewska","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.152727_bib43","first-page":"64","article-title":"Branched-chain amino acid metabolism in cancer","volume":"21","author":"Ananieva","year":"2018","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbrc.2025.152727_bib44","article-title":"Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions","volume":"13","author":"Xu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.152727_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115741","article-title":"Acetyl-CoA metabolism as a therapeutic target for cancer","volume":"168","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2025.152727_bib46","article-title":"Principal component analysis: a review and recent developments","volume":"374","author":"Jolliffe","year":"2016","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.bbrc.2025.152727_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.bbrc.2025.152727_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/bioadv\/vbad125","article-title":"Immuno-metabolic signaling in leishmaniasis: insights gained from mathematical modeling","volume":"3","author":"Khandibharad","year":"2023","journal-title":"Bioinforma. Adv"},{"key":"10.1016\/j.bbrc.2025.152727_bib49","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1158\/0008-5472.CAN-23-2729","article-title":"Genome-wide CRISPR screens identify multiple synthetic lethal targets that enhance KRASG12C inhibitor efficacy","volume":"83","author":"Mukhopadhyay","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2025.152727_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.lungcan.2018.07.013","article-title":"KRAS-mutant non-small cell lung cancer: from biology to therapy","volume":"124","author":"Ferrer","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbrc.2025.152727_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.semcdb.2019.06.004","article-title":"Exploiting metabolic vulnerabilities of non small cell lung carcinoma","volume":"98","author":"Majem","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2025.152727_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104037","article-title":"Therapeutic strategies targeting metabolic characteristics of cancer cells","volume":"187","author":"Bai","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25014433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25014433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:34:03Z","timestamp":1773135243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25014433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":52,"alternative-id":["S0006291X25014433"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152727","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting IL-6\/STAT3 signaling to mitigate sarcopenia: Insights from immuno-metabolic crosstalk in NSCLC","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152727"}}